Showing 7611-7620 of 20409 results for "".
Examining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
https://reachmd.com/programs/project-oncology/examining-unmet-needs-in-paroxysmal-nocturnal-hemoglobinuria/48877/What are the current treatment options for patients with PNH? And what are the limitations?Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria
https://reachmd.com/programs/project-oncology/examining-the-treatment-paradigm-for-paroxysmal-nocturnal-hemoglobinuria/48880/Join us as we take a closer look at the current treatment options available for paroxysmal nocturnal hemoglobinuria.Burden and pathophysiology of APOL1 kidney disease
https://reachmd.com/programs/kdigo-conversations-nephrology/burden-and-pathophysiology-of-apol1-kidney-disease/35711/Burden and pathophysiology of APOL1 kidney diseaseClosing Meningococcal Protection Gaps: The Case for Combination Vaccines
https://reachmd.com/programs/vaccination/closing-meningococcal-protection-gaps-the-case-for-combination-vaccines/37108/Despite high uptake of the quadrivalent meningococcal ACWY vaccine among adolescents, significant protection gaps remain, particularly against serogroup B. That’s why Dr. Ruth Carrico joins us to examine key challenges in adolescent vaccine delivery and how newer pentavalent vaccines covering all fiTackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
https://reachmd.com/programs/eye-on-ocular-health/tackling-the-myopia-epidemic-causes-consequences-and-opportunities-for-prevention/36286/Myopia is on the rise globally, with nearly half the world’s population projected to be affected by 2050. However, rates vary significantly across regions and demographics due to a mix of genetic, environmental, and behavioral factors. So to learn more about the complex drivers behind this troublingAndrogen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
https://reachmd.com/programs/project-oncology/androgen-receptor-emerges-as-a-marker-of-differentiation-in-endometrial-cancer/35511/Read about emerging data positioning the androgen receptor as a complementary biomarker for stratifying hormone-responsive endometrial cancer.Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/advancing-patient-centered-care-in-her2-positive-metastatic-breast-cancer/35461/When treating patients with metastatic breast cancer, effective communication and patient support are key. Join Dr. Megan Kruse, a medical oncologist at Cleveland Clinic in Ohio, as she explains how to align treatment goals with patient values, address physical and emotional needs through multidisciScalp Psoriasis Care: When Should Systemic Therapy Be Considered?
https://reachmd.com/programs/frontlines-psoriasis/scalp-psoriasis-care-when-should-systemic-therapy-be-considered/32438/Systemic therapies can be helpful in managing scalp psoriasis, even if a patient has low body surface area. Hear key factors for determining when to use them.Dr. Dawn K. Smith HIV Prevention Clinical Fellowship Announced at CROI 2024
https://reachmd.com/programs/clinicians-roundtable/dr-dawn-k-smith-hiv-prevention-clinical-fellowship-announced-at-croi-2024/18002/The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship was announced at CROI 2024. Read more for details.Exploring Approaches to Management for Bronchiectasis
https://reachmd.com/programs/deep-breaths-updates-chest/exploring-approaches-to-management-for-bronchiectasis/14879/Learn more about the burden of bronchiectasis exacerbations, and how clinicians can manage this condition.